×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agenda
Session 2 - Policy Considerations
Session Chair(s)
David Gaugh, RPh
Senior Vice President for Sciences and Regulatory Affairs
Generic Pharmaceutical Association (GPhA), United States
Speaker(s)
Will State Law Substitution Statues and Unique Naming Restrict Biologic Innovation?
Bruce Leicher, JD
Momenta Pharmaceuticals, Inc., United States
Senior Vice President and General Counsel
Ed Clere
State of Indiana House of Representatives, United States
Representative, Indiana House Republicans
Pharmocovigilance
Thomas Felix, MD
Amgen Inc., United States
Medical Director, R&D Policy, Global Regulatory Affairs and Safety
Panel Discussion: Joining the Session Speakers
Gerald McEvoy, PharmD
American Society of Health-System Pharmacists, United States
Assistant Vice President of Drug Information
Have an account?